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  EVIDENCE-BASED ANSWER 
Osgood-Schlatter disease is a common cause of pain and tenderness at the tibial tuberosity in active 
adolescents. It is typically a self-limited condition that waxes and wanes, but which often takes months to years 
to resolve entirely. It is best managed with conservative measures (activity modification, ice, anti-inflammatory 
agents) and time (strength of recommendation [SOR]: B, several case series and retrospective studies). 
In chronic cases that are refractory to conservative treatment, surgical intervention yields good results, 
particularly for patients with bony or cartilaginous ossicles. Excision of these ossicles produces resolution of 
symptoms and return to activity in several weeks (SOR: C, several case series). Corticosteroid injections are 
not recommended (SOR: C, case reports and expert opinion). 
  EVIDENCE SUMMARY 
No prospective, interventional studies evaluate the treatment of Osgood-Schlatter disease. One case series 
followed the natural course of the disease in 261 patients (365 symptomatic knees) for 12 to 24 months; 237 
(90.8%) patients responded well to restriction of sports activity and nonsteroidal anti-inflammatory agents. The 
24 patients who did not improve with conservative measures underwent surgical excision of ossicles, and all 
returned to normal activities (mean time, 4.5 weeks).1 
In another case series of 118 patients (151 knees), 88% responded to intermittent limitation of activity (weeks 
to months) or cylinder casting if limiting activity was ineffective. The remaining 14 patients showed no 
improvement from these measures; all had surgical excision of an ossicle, sometimes combined with a 
tubercle-thinning procedure. Only 1 of these patients (7%) did not have complete relief and return to full 
activities at 6 weeks.2 
Retrospective analyses also support a conservative approach. One retrospective survey of 68 young athletes 
with Osgood-Schlatter found they required an average of 3.2 months off all training and 7.3 months of some 
activity restrictions.3 In another survey, 20 of 22 (91%) adolescent athletes with Osgood-Schlatter were able to 
manage their symptoms with ice, aspirin, and mild activity modification. Only 2 needed to stop playing all sports 
for any period of time, and none required surgery.4 
Another retrospective review analyzed 50 patients with Osgood-Schlatter (69 knees) for an average of 9 years. 
No treatments or activity restrictions were recommended. At time of follow-up, 36 (76%) had no limitations, but 
kneeling continued to be uncomfortable in 60%.5 
No interventional studies have explicitly evaluated commonly recommended conservative treatments such as 
ice, analgesics, activity restriction, stretching, strengthening, or anti-inflammatory medication. Corticosteroid 
injections are generally not recommended, due to case reports of complications, primarily related to 
subcutaneous atrophy.6 One small case series demonstrated improvement in Osgood-Schlatter disease pain in 
19 of 24 (79%) knees after using an infrapatellar strap for 6 to 8 weeks.7 
Refractory cases have been treated with a variety of surgical interventions. In 1 case series, 67 patients (70 
knees) (mean age 19.6, 77% male) with at least 18 months of symptoms despite conservative treatment 
underwent resection of an ossicle (62 cases) or excision of prominent tibial tubercle (8 cases). These patients 
were followed for 2.2 years, with 56 (90%) patients with ossicle-resection able to return to maximal sports 
activity without pain, tenderness, loss of motion, or atrophy.8 
Another case series compared 22 patients who1 underwent drilling of the tibial tubercle (with or without the 
removal of the tibial tubercle) with 22 patients who had excision of loose ossicles or cartilage. Seventeen of the 
22 (77%) patients with ossicle excision had complete resolution of symptoms compared with 8 of the 22 (36%) 
in the patients who underwent tibial tubercle drilling.9 
One surgical series evaluated excision of tibial tuberosity in 35 patients (42 knees) who did not improve with 
conservative treatment for an average of 13.25 months. For 37 of 42 knees (88%), patients reported complete 
relief of pain, and all returned to activity without limitation. The average time to return to sports was 15.2 
weeks.10 
  RECOMMENDATIONS FROM OTHERS 
The American Academy of Orthopaedic Surgeons and the American Academy of Family Practice recommend 
activity limitation, ice, anti-inflammatories, protective padding, quadriceps/hamstring strengthening, and time in 
the management of Osgood-Schlatter disease.11,12 
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Few patients have poor results with conservative measures 
Osgood-Schlatter disease is a common problem that all primary care physicians must be 
ready to recognize and treat. While the research (primarily surgical series) indicates that 
10% to 12% of patients may not improve with conservative measures, I have not had 
nearly that high a percentage of patients who require surgical intervention. Surgery is only 
offered after the tubercle attaches to the femur, or the tubercle fails to attach at all. In fact, 
I do not x-ray typical cases of Osgood-Schlatter disease unless evidence suggests patella 
tendon avulsion, or if parental concern is high. This means that, in most cases, the 
primary care physician has quite a while to try conservative measures before incurring the 
expense of radiography or an orthopedic consultation. 
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D R U G  B R A N D  N A M E S  
Candesartan • Atacand 
Felodipine • Plendil 
Spironolactone • Aldactone 
Valsartan • Diovan 
 
